Not Yet Recruiting
A Study of Cladribine, Low Dose Cytarabine, and Venetoclax in Treatment of Relapsed/Refractory or Secondary Acute Myeloid Leukemia
NCT07423104
- Conditions
- Acute Myeloid Leukemia (AML), Disease Attributes, Hematologic Diseases, +9 more
- Locations
-
Not specified